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Meart Failure With Normal Left
entricular Ejection Fraction May
e Due to Systolic Dysfunction
urther to the review article on heart failure with a normal ejection
raction (HFNEF) (1), the authors note that HFNEF is associated
ith hypertension in up to 88% of individuals. Observational
tudies have shown that there is a significant increase in left
entricular mass but with a relatively normal end-diastolic volume
ompared with control patients (2). The authors also confirm that
here are contractile abnormalities as assessed by strain, strain rate,
nd peak annular systolic velocities (1,3). Interestingly, systolic
elocities correlate (r  0.81) with the severity of the diastolic
elocities in both heart failure with preserved ejection fraction and
n heart failure with a reduced ejection fraction (4). An example of
nonhypertensive etiology of HFNEF is sarcomeric hypertrophic
ardiomyopathy. This disorder is associated with myocardial dis-
rray and is caused by a number of gene abnormalities, each of
hich encodes a contractile protein; both of these abnormalities
ould be expected to cause contractile dysfunction, and yet the
jection fraction is usually normal or increased.
This apparent contradiction of a normal ejection fraction with
idespread (i.e., global) and significant contractile abnormalities in
FNEF is difficult to understand. However, it is plausible that an
ncrease in left ventricular end-diastolic wall thickness would lead
o greater thickening in systole given the same longitudinal and
id-wall circumferential shortening. Therefore, in the presence of
ontractile dysfunction and concentric left ventricular hypertrophy,
adial wall thickening (end-systolic wall thickness minus end-
iastolic wall thickness) could be within normal limits. The
xternal volume of the heart alters little during the cardiac cycle;
herefore, the inward endocardial displacement, endocardial frac-
ional shortening, and ejection fraction would be normal. In
ummary, at least some examples of HFNEF may be explained
y the combination of concentric left ventricular hypertrophy
nd contractile dysfunction despite the ejection fraction being
reserved (5).
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eply
n an attempt to further reconcile the paradoxical finding of a
ormal left ventricular ejection fraction (LVEF) in patients with
eart failure with normal ejection fraction (HFNEF), Dr. MacIver
roposes that left ventricular (LV) hypertrophy per se augments
all thickening and thereby maintains LVEF in the presence of
mpaired contractility. While conceptually this may be plausible,
he evidence for such a mechanism appears limited. Contrary to
his proposition, previous studies have demonstrated that in the
resence of lower longitudinal systolic myocardial velocity and
ariable changes in radial strain, patients with HFNEF or subclin-
cal LV diastolic dysfunction have preserved LVEF in the absence
f a significant rise in LV mass (1,2). The mechanism by which
his apparent compensation occurs is not clear; however, it has
een proposed that preserved circumferential strain and LV twist
ay contribute (2). These changes may be the result of the relative
ypertrophy of mid-wall myocytes, realignment of myocytes, or
lterations in the pattern of mechanical activation of fibers of
arying spatial orientation resulting in changes in their afterload
ccording to the time of contraction.
Whereas the presence of LV hypertrophy, for example in
ypertrophic cardiomyopathy, may be associated with a normal or
ven high LVEF, studies suggest that wall thickening is reduced
nd that the preserved LVEF is a function of a smaller LV end
iastolic volume (3).
Currently, the key clinical challenge in each patient with a
iagnosis of HFNEF is to develop a comprehensive understanding
f the pathophysiologic basis of their symptoms on an individual
asis. In many cases, it may be difficult to resolve whether
ymptoms are due to intrinsic LV dysfunction, or whether addi-
ional factors such as impaired vasodilatory response, impaired
hronotropic competence, fluid overload, ventriculo-vascular mis-
atch (4), or as suggested very recently, abnormal pulmonary
ascular reactivity (5) might play a role. The adoption of other
ssessment modalities may also be required, including a formal
valuation of the hemodynamic response to exercise to shed light
n the pathophysiology of this poorly understood and difficult to
anage disease.
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